Glenmark Generics Inc. USA (GGI), a subsidiary of Glenmark Pharmaceuticals, has received approval from the US FDA for lithium carbonate 150 mg, 300 mg and 600 mg capsules and will immediately commence marketing and distribution of these products in the US market.
The details can be read here.
No comments:
Post a Comment